Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Express Scripts
Argus Health
McKesson
Julphar
Baxter
Johnson and Johnson
Dow
Fish and Richardson
US Army

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,227,490

« Back to Dashboard

Which drugs does patent 8,227,490 protect, and when does it expire?

Patent 8,227,490 protects LOPROX and is included in one NDA.

This patent has forty-one patent family members in thirty-three countries.
Summary for Patent: 8,227,490
Title:Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis. ##STR00001##
Inventor(s): Bohn; Manfred (Hofheim, DE), Kraemer; Karl Theodor (Langen, DE), Markus; Astrid (Liederbach, DE)
Assignee: Medicis Pharmaceutical Corporation (Scottsdale, AZ)
Application Number:13/177,710
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,227,490

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 AT RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF SEBORRHEIC DERMATITIS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,227,490

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany196 39 818Sep 27, 1996

Non-Orange Book US Patents Family Members for Patent 8,227,490

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,981,909 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,227,490

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
South Korea 100494207 ➤ Subscribe
Morocco 24333 ➤ Subscribe
Malaysia 125674 ➤ Subscribe
Norway 991460 ➤ Subscribe
Norway 312492 ➤ Subscribe
New Zealand 334850 ➤ Subscribe
African Intellectual Property Organization (OAPI) 11028 ➤ Subscribe
Poland 332603 ➤ Subscribe
Poland 188033 ➤ Subscribe
Portugal 928183 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cipla
Cerilliant
Queensland Health
Dow
Accenture
McKinsey
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot